Back to GSK Stock Lookup
Pages: 1 2 »» Last Page

GSK – Rumors

Nov 21, 2013 11:03 AM BioMarin (BMRN) May Draw Interest Following Recent FDA Panel Vote (PFE) (RHHBY)
Jul 9, 2013 02:38 PM Recnt Dip in Allergan (AGN) Shares Might Have Bidders Lining Up (GSK) (MRK)
Apr 2, 2013 09:33 AM Optimer Pharma (OPTR) Said to Draw Interest from Glaxo (GSK), Astellas
Mar 25, 2013 08:12 AM Acquisition of Theravance (THRX) Might be Best Option for Glaxo (GSK)
Feb 20, 2013 09:57 AM InterMune (ITMN) Could Draw Bids as IPF Treatment Esbriet Gains Strength
Nov 21, 2012 01:38 PM Amarin (AMRN) Ramps as BASF's Pronova Takeover Highlights Value
Jul 16, 2012 06:37 AM Human Genome Sciences (HGSI) Agrees to $14/Share Takeover from GSK (GSK) - Reports
Jul 9, 2012 09:46 AM Arena Pharma (ARNA) Higher as M&A Chatter Heats Up
Jul 9, 2012 08:44 AM A Celgene (CELG) / Human Genome Sciences (HGSI) Deal Seen as Unlikely
Jun 29, 2012 06:59 AM Human Genome (HGSI) Could Get 15% More in Takeover Bid - Analyst
Jun 28, 2012 12:22 PM BioMarin (BMRN) Moves on Renewed Takeover Chatter
Jun 15, 2012 08:19 AM Is Human Genome (HGSI) Getting Desperate for a Deal?
Jun 12, 2012 03:49 PM Piper Jaffray Says BioMarin (BMRN) Could Be Taken Out for $52-$70/Share
Jun 12, 2012 08:31 AM BioMarin (BMRN) Higher as Takeover Chatter Swirls
May 30, 2012 10:19 AM Human Genome (HGSI) Shares Moving as Reuters Says Glaxo (GSK) Wants to Replace Entire Board
May 17, 2012 07:06 AM Human Genome Sciences (HGSI) Unanimously Rejects GlaxoSmithKline (GSK) Offer
May 9, 2012 06:52 AM GlaxoSmithKline (GSK) Commence $13/Share Tender Offer for Human Genome Sciences (HGSI)
Apr 19, 2012 08:06 AM Glaxo's Bid for Human Genome Is a Positive for Anthera Pharma (ANTH) - Analyst
Apr 19, 2012 07:14 AM Human Genome (HGSI) Trades Well Above GSK Offer, Other Biotechs See Action
Apr 12, 2012 11:10 AM UPDATE - UBS Initiates Coverage on Human Genome (HGSI) with a Neutral; See Stock Range-Bound as GSK Hovers
Mar 7, 2012 10:17 AM GlaxoSmithKline (GSK) Seeking Buyer for European Non-Core Drugs Portfolio -IBT
Oct 18, 2011 12:33 PM Piper Jaffray Sees Human Genome (HGSI) Selling for $21-$26/Share in Takeover
Oct 18, 2011 08:11 AM Glaxo (GSK) Could Bid $25/Share for Human Genome (HGSI) -UK's Mail
Oct 6, 2011 12:29 PM Shares of Anadys (ANDS) Trade Above $1; Analyst Believes Co. Could Get a Bid Following Setrobuvir Data
Nov 11, 2010 05:52 PM Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta
Sep 22, 2010 05:08 PM Savient Pharmaceuticals (SVNT) Continues Surge On Takeover Speculation
Sep 15, 2010 02:38 PM Leerink Swann Raises Target on Savient (SVNT) to $22; Highlights Takeover Potential Following Krystexxa Approval
Jul 26, 2010 01:01 PM Wall Street Hubbub 7/26: A Genzyme (GENZ) Deal Coming, Is Biogen Idec (BIIB) Next, New BP CEO, Goldman Sachs the Movie
Apr 12, 2010 12:23 PM Abraxis Bioscience (ABII) Reportedly Puts Itself Up for Sale
Mar 12, 2010 08:36 AM Piper Jaffray Assumes Coverage on Human Genome Sciences (HGSI) with an Overweight; Benlysta's First Mover Advantage Key to $4bn+ Opportunity
Oct 15, 2009 06:56 AM Goldman Sachs Resumes Human Genome Sciences (HGSI) at Buy, Sees As Potential Takeover Target
Sep 18, 2009 01:46 PM Human Genome (HGSI) Up On More Takeover Talk
Sep 14, 2009 03:19 PM Human Genome Sciences (HGSI) Climbs Higher On Takeover Speculation
Aug 25, 2009 11:59 AM Human Genome (HGSI) Shares Spike as GlaxoSmithKline (GSK) Rumored to Have $30/Share Bid Ready
May 22, 2009 02:41 PM Novartis (NVS), Sanofi-Aventis (SNY), Glaxo (GSK) to Receive $661M of $1B Set Side for Developing H1N1 Flu Vaccine -CNBC
Apr 7, 2009 12:58 PM Biogen Idec (BIIB) Rises On Renewed Takeover Talk
Mar 24, 2009 02:23 PM Allergan (AGN) call volume and volatility Spike on Speculation
Sep 10, 2008 10:19 AM Analyst Expects Immediate $70/Share Offer for ImClone (IMCL) from Bristol-Myers Following News
Jul 31, 2008 10:14 AM Biotech Takeover Buzz Hot and Heavy After ImClone Offer (ONXX, OSIP, BIIB, AMLN, XPNT, CYPB, ISPH)
Jan 18, 2008 11:52 AM AstraZeneca (AZN) Up on Glaxosmithkline Buyout Chatter
Oct 24, 2007 07:52 AM Reports Glaxosmithkline's CEO No Comment on Biogen Idec (BIIB) Interest
Jul 6, 2007 02:53 PM Market Rumors 07/06
Jul 5, 2007 05:15 PM Is a Super-Secretive Hedge Fund Targeting Flamel Technologies (FLML) for Activism?
Oct 31, 2006 09:03 AM Needham Comments on Other Stocks in RNAi Following Merck's Deal to Buy Sirna Therapeutics
Sep 15, 2006 01:38 PM Bristol-Myers (BMY) and Schering-Plough (SGP) Higher On Rumored Deal
Jun 19, 2006 02:01 PM Sepracor (SEPR) Spokeswomen 'No Comment' On Takeover Talk, Shares Surge
May 24, 2006 03:32 PM Sepracor (SEPR) Sees Upside on Renewed Takeover Chatter
Apr 10, 2006 10:44 AM Serono (SRA) Sinks After Sales Process Ends Unsuccessfully
Jan 30, 2006 12:21 AM Reports GSK Restarts Talks for SRA
Jan 25, 2006 03:18 PM VRTX Seen As Possible Target for Merck
Pages: 1 2 »» Last Page

Back to GSK Stock Lookup